▶ 調査レポート

世界の末梢神経障害治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の末梢神経障害治療市場規模・現状・予測(2021年-2027年) / Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027 / QYR2104Z4521資料のイメージです。• レポートコード:QYR2104Z4521
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥553,800 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥830,700 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,107,600 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、末梢神経障害治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他)、用途別市場規模(プラチナ剤、タキサン、ビンカアルカロイド、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・末梢神経障害治療の市場動向
・企業の競争状況、市場シェア
・末梢神経障害治療の種類別市場規模(カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他)
・末梢神経障害治療の用途別市場規模(プラチナ剤、タキサン、ビンカアルカロイド、その他)
・末梢神経障害治療の北米市場規模2016-2027(アメリカ、カナダ)
・末梢神経障害治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・末梢神経障害治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・末梢神経障害治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・末梢神経障害治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Eli Lilly、Johnson & Johnson、Novartis、Pfizer、Aptinyx、Regenacy Pharmaceuticals、TEVA Pharmaceutical Industries、Immune Pharmaceuticals)
・結論

Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.

Market Analysis and Insights: Global Peripheral Neuropathy Treatment Market
The global Peripheral Neuropathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Neuropathy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Neuropathy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Neuropathy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Neuropathy Treatment market.

Global Peripheral Neuropathy Treatment Scope and Market Size
Peripheral Neuropathy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Neuropathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others

Segment by Application
Platinum Agents
Taxanes
Vinca Alkaloids
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Johnson & Johnson
Novartis
Pfizer
Aptinyx
Regenacy Pharmaceuticals
TEVA Pharmaceutical Industries
Immune Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Calcium Channel α2-delta Ligands
1.2.3 Antidepressants
1.2.4 Opioids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peripheral Neuropathy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Platinum Agents
1.3.3 Taxanes
1.3.4 Vinca Alkaloids
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peripheral Neuropathy Treatment Market Perspective (2016-2027)
2.2 Peripheral Neuropathy Treatment Growth Trends by Regions
2.2.1 Peripheral Neuropathy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral Neuropathy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral Neuropathy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral Neuropathy Treatment Industry Dynamic
2.3.1 Peripheral Neuropathy Treatment Market Trends
2.3.2 Peripheral Neuropathy Treatment Market Drivers
2.3.3 Peripheral Neuropathy Treatment Market Challenges
2.3.4 Peripheral Neuropathy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peripheral Neuropathy Treatment Players by Revenue
3.1.1 Global Top Peripheral Neuropathy Treatment Players by Revenue (2016-2021)
3.1.2 Global Peripheral Neuropathy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral Neuropathy Treatment Revenue
3.4 Global Peripheral Neuropathy Treatment Market Concentration Ratio
3.4.1 Global Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Neuropathy Treatment Revenue in 2020
3.5 Peripheral Neuropathy Treatment Key Players Head office and Area Served
3.6 Key Players Peripheral Neuropathy Treatment Product Solution and Service
3.7 Date of Enter into Peripheral Neuropathy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peripheral Neuropathy Treatment Breakdown Data by Type
4.1 Global Peripheral Neuropathy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2022-2027)

5 Peripheral Neuropathy Treatment Breakdown Data by Application
5.1 Global Peripheral Neuropathy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peripheral Neuropathy Treatment Market Size (2016-2027)
6.2 North America Peripheral Neuropathy Treatment Market Size by Type
6.2.1 North America Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
6.2.2 North America Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
6.2.3 North America Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
6.3 North America Peripheral Neuropathy Treatment Market Size by Application
6.3.1 North America Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
6.3.2 North America Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
6.3.3 North America Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
6.4 North America Peripheral Neuropathy Treatment Market Size by Country
6.4.1 North America Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
6.4.2 North America Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Peripheral Neuropathy Treatment Market Size (2016-2027)
7.2 Europe Peripheral Neuropathy Treatment Market Size by Type
7.2.1 Europe Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
7.3 Europe Peripheral Neuropathy Treatment Market Size by Application
7.3.1 Europe Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
7.4 Europe Peripheral Neuropathy Treatment Market Size by Country
7.4.1 Europe Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peripheral Neuropathy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Type
8.2.1 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Application
8.3.1 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region
8.4.1 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peripheral Neuropathy Treatment Market Size (2016-2027)
9.2 Latin America Peripheral Neuropathy Treatment Market Size by Type
9.2.1 Latin America Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
9.3 Latin America Peripheral Neuropathy Treatment Market Size by Application
9.3.1 Latin America Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
9.4 Latin America Peripheral Neuropathy Treatment Market Size by Country
9.4.1 Latin America Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peripheral Neuropathy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Type
10.2.1 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Application
10.3.1 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country
10.4.1 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Peripheral Neuropathy Treatment Introduction
11.1.4 Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Peripheral Neuropathy Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Peripheral Neuropathy Treatment Introduction
11.3.4 Novartis Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Peripheral Neuropathy Treatment Introduction
11.4.4 Pfizer Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Aptinyx
11.5.1 Aptinyx Company Details
11.5.2 Aptinyx Business Overview
11.5.3 Aptinyx Peripheral Neuropathy Treatment Introduction
11.5.4 Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.5.5 Aptinyx Recent Development
11.6 Regenacy Pharmaceuticals
11.6.1 Regenacy Pharmaceuticals Company Details
11.6.2 Regenacy Pharmaceuticals Business Overview
11.6.3 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Introduction
11.6.4 Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.6.5 Regenacy Pharmaceuticals Recent Development
11.7 TEVA Pharmaceutical Industries
11.7.1 TEVA Pharmaceutical Industries Company Details
11.7.2 TEVA Pharmaceutical Industries Business Overview
11.7.3 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Introduction
11.7.4 TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.7.5 TEVA Pharmaceutical Industries Recent Development
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Details
11.8.2 Immune Pharmaceuticals Business Overview
11.8.3 Immune Pharmaceuticals Peripheral Neuropathy Treatment Introduction
11.8.4 Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2016-2021)
11.8.5 Immune Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Calcium Channel α2-delta Ligands
Table 3. Key Players of Antidepressants
Table 4. Key Players of Opioids
Table 5. Key Players of Others
Table 6. Global Peripheral Neuropathy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peripheral Neuropathy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peripheral Neuropathy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Peripheral Neuropathy Treatment Market Share by Regions (2016-2021)
Table 10. Global Peripheral Neuropathy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Peripheral Neuropathy Treatment Market Share by Regions (2022-2027)
Table 12. Peripheral Neuropathy Treatment Market Trends
Table 13. Peripheral Neuropathy Treatment Market Drivers
Table 14. Peripheral Neuropathy Treatment Market Challenges
Table 15. Peripheral Neuropathy Treatment Market Restraints
Table 16. Global Peripheral Neuropathy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Peripheral Neuropathy Treatment Market Share by Players (2016-2021)
Table 18. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Neuropathy Treatment as of 2020)
Table 19. Ranking of Global Top Peripheral Neuropathy Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Peripheral Neuropathy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peripheral Neuropathy Treatment Product Solution and Service
Table 23. Date of Enter into Peripheral Neuropathy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Peripheral Neuropathy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Peripheral Neuropathy Treatment Product
Table 66. Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Peripheral Neuropathy Treatment Product
Table 71. Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Peripheral Neuropathy Treatment Product
Table 76. Novartis Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Peripheral Neuropathy Treatment Product
Table 81. Pfizer Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Aptinyx Company Details
Table 84. Aptinyx Business Overview
Table 85. Aptinyx Peripheral Neuropathy Treatment Product
Table 86. Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 87. Aptinyx Recent Development
Table 88. Regenacy Pharmaceuticals Company Details
Table 89. Regenacy Pharmaceuticals Business Overview
Table 90. Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Product
Table 91. Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 92. Regenacy Pharmaceuticals Recent Development
Table 93. TEVA Pharmaceutical Industries Company Details
Table 94. TEVA Pharmaceutical Industries Business Overview
Table 95. TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Product
Table 96. TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 97. TEVA Pharmaceutical Industries Recent Development
Table 98. Immune Pharmaceuticals Company Details
Table 99. Immune Pharmaceuticals Business Overview
Table 100. Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 101. Immune Pharmaceuticals Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Neuropathy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Calcium Channel α2-delta Ligands Features
Figure 3. Antidepressants Features
Figure 4. Opioids Features
Figure 5. Others Features
Figure 6. Global Peripheral Neuropathy Treatment Market Share by Application: 2020 VS 2027
Figure 7. Platinum Agents Case Studies
Figure 8. Taxanes Case Studies
Figure 9. Vinca Alkaloids Case Studies
Figure 10. Others Case Studies
Figure 11. Peripheral Neuropathy Treatment Report Years Considered
Figure 12. Global Peripheral Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Peripheral Neuropathy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Peripheral Neuropathy Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Peripheral Neuropathy Treatment Market Share by Regions (2022-2027)
Figure 16. Global Peripheral Neuropathy Treatment Market Share by Players in 2020
Figure 17. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Neuropathy Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Neuropathy Treatment Revenue in 2020
Figure 19. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 23. North America Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 24. North America Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 25. United States Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 29. Europe Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 30. Europe Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 31. Germany Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Peripheral Neuropathy Treatment Market Share by Region (2016-2027)
Figure 41. China Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Peripheral Neuropathy Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Peripheral Neuropathy Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Peripheral Neuropathy Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Peripheral Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Eli Lilly Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 64. Aptinyx Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 65. Regenacy Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 66. TEVA Pharmaceutical Industries Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 67. Immune Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed